Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Mar;36(3):169-75.
doi: 10.1007/s40261-015-0368-5.

The Safety of Melatonin in Humans


The Safety of Melatonin in Humans

Lars Peter Holst Andersen et al. Clin Drug Investig. .


Exogenous melatonin has been investigated as treatment for a number of medical and surgical diseases, demonstrating encouraging results. The aim of this review was to present and evaluate the literature concerning the possible adverse effects and safety of exogenous melatonin in humans. Furthermore, we provide recommendations concerning the possible risks of melatonin use in specific patient groups. In general, animal and human studies documented that short-term use of melatonin is safe, even in extreme doses. Only mild adverse effects, such as dizziness, headache, nausea and sleepiness have been reported. No studies have indicated that exogenous melatonin should induce any serious adverse effects. Similarly, randomized clinical studies indicate that long-term melatonin treatment causes only mild adverse effects comparable to placebo. Long-term safety of melatonin in children and adolescents, however, requires further investigation. Due to a lack of human studies, pregnant and breast-feeding women should not take exogenous melatonin at this moment.

Similar articles

See all similar articles

Cited by 40 articles

See all "Cited by" articles


    1. J Clin Endocrinol Metab. 1977 Oct;45(4):768-74 - PubMed
    1. Aviat Space Environ Med. 2003 Dec;74(12 ):1263-70 - PubMed
    1. Nature. 1967 May 27;214(5091):919-20 - PubMed
    1. Eur J Clin Pharmacol. 2001 Aug;57(5):419-25 - PubMed
    1. Hum Psychopharmacol. 2008 Dec;23(8):693-705 - PubMed